You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 6, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
Markryan Dwyer1, Mihaela Gadjeva
1Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
The opsonophagocytic killing (OPK) assay measures how well antibodies from vaccine candidates work. This study presents two protocols for the OPK assay using human neutrophils or HL-60 cells to assess vaccine efficacy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: